When Is 'Open' Software Not So Open?

By BIO-IT World

December 15, 2003 | When the license restricts modifications and distribution, that's when. Read the fine print.

Unfortunately, there is no single, official definition of open- source software (OSS). Rather, there are variations on a licensing theme. In other words, OSS can best be defined and understood by a list of required licensing terms that apply to the use, modification, and distribution of the software.

The most widely recognized licensing terms have three core requirements:

  • Mandatory availability of source code

  • The right to use and redistribute the source code freely by anybody to anybody for any purpose

  • A requirement to make derivative works available on like terms

While the Open Source Initiative, a nonprofit organization, promotes one widely accepted definition of "open source," even the OSI Web site offers a menu of alternatives, with the GPL (Gnu Public License), for example, as one substitute definition and a commonly used form of license. The OSI has developed its own certification program for OSS, and there are now more than 40 types of certified OSS licenses, with many more, in varying degrees, based on the consensus OSS requirements.

Many licenses include some but not all of the above OSS requirements, however, and some software is made available under more than one form of license — for example, an OSS license and a proprietary license. Examples include "freeware," which often allows for unrestricted use of the software with no further restrictions on the user apart from copyright notices, or the Perl "Artistic License" and the Sun licenses governing Java, which include restrictions on modifications and distribution of the software.

"Public domain" software, on the other hand, is freely available with no restrictions on use, modification, or distribution, by declaration of the author(s).


Back to The Hidden Costs of 'Free' Software 


White Papers & Special Reports

Coupa white paper 92
10 Secrets to Recession-Proof Your Business
Sponsored by Coupa


Read this white paper to discover 10 strategies smart companies deploy to recession-proof their business.
Leaders generally face hard choices on how to mange a company during an economic downturn and
behave in one of three ways:
1) “The ostrich” - Preserve the status quo/hope for the best
2) “The bull in the china shop” - Blindly cut expenses across the board
3) “The fox” - Use the downturn to make your business more effective and position it for future growth

Learn how to behave “like a fox” and use a recession as a means to pounce on emerging trends.



SGI BriefingON image
High-Performance Computing in Life Science & Education
Sponsored by SGI and Intel
The varied collection of Bio-IT World articles and insights assembled in this BriefingON examine key trends in HPC infrastructure and how researchers are putting their best computational resources to use. Provided here are stories and lessons around the effective use of high performance computing in life science. Download the BriefingON.


Waters white paper image
Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms 

medidata podcastProtocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now 



More Podcasts

Job Openings

Director, Center For Information Technology (CIT) - National Institutes of Health  (NIH), Department of Health and Human Service
Located in Bethesda, MD. This position requires:
• High-level vision, leadership, management, and modernization of CIT programs and services.
• Strategic direction and policy development for CIT long-term operations and objectives.
• Serve as a key IT advisor to the NIH Chief Information Officer.
A TOP SECRET security clearance will be required.  More job detail is found at:  http://www.jobs.nih.gov under the Executive Jobs section.Or contact Ms.Winnie Garner at seniorre@od.nih.gov.  Applications must be received ELECTRONICALLY by (11:59 p.m.), December 17, 2008.  DHHS and NIH are Equal Opportunity Employers

Bioinformatics Manager- Lilly Singapore Centre for Drug Discovery
For more information click here 

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.